Free Newsletter
| Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today! |
SPOTLIGHT: High Court won't hear "Zoloft defense"
The U.S. Supreme Court has refused to hear an appeal in the infamous "Zoloft defense" case of a teen sentenced to 30 years for killing his grandparents with a shotgun. The case attracted nationwide attention when the child's lawyers blamed his violent behavior on the antidepressant Zoloft. Report
Be the first to comment
More stories about Supreme Court
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
- Forecast Model: Antidyslipidemics - Genericization and negative trial data drive market shrinkage
